tolvaptan has been researched along with Pleural Effusion in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Iida, H; Kaida, S; Maehira, H; Maekawa, T; Miyake, T; Mori, H; Nitta, N; Takebayashi, K; Tani, M | 1 |
Aoyama, R; Harada, K; Ishikawa, J | 1 |
Adachi, O; Akiyama, M; Fujiwara, H; Kanda, K; Katahira, S; Kawamoto, S; Kawatsu, S; Kumagai, K; Saiki, Y; Sakatsume, K; Suzuki, T; Takahara, S | 1 |
3 other study(ies) available for tolvaptan and Pleural Effusion
Article | Year |
---|---|
Effect of early administration of tolvaptan on pleural effusion post-hepatectomy.
Topics: Body Weight; Hepatectomy; Humans; Pleural Effusion; Risk Factors; Tolvaptan | 2023 |
The efficacy of tolvaptan in treating dasatinib-induced pleural effusions in patients with chronic myelogenous leukemia.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents; Dasatinib; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pleural Effusion; Protein Kinase Inhibitors; Retrospective Studies; Tolvaptan; Treatment Outcome | 2020 |
[Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis].
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Humans; Male; Pericarditis, Constrictive; Pleural Effusion; Preoperative Care; Tolvaptan; Tomography, X-Ray Computed | 2016 |